A detailed history of Advisory Services Network, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Advisory Services Network, LLC holds 854 shares of KRYS stock, worth $176,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares
854
Holding current value
$176,060
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 18, 2025

BUY
$134.94 - $176.75 $115,238 - $150,944
854 New
854 $150,000
Q4 2023

Feb 09, 2024

BUY
$96.0 - $128.29 $192 - $256
2 New
2 $0

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $5.29B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.